LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.57
-0.11 (-16.18%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,356.1% upside
Low Target
$9.32
Average Target
$14.00
High Target
$16.42
Current Price
$0.57
Current
$0.57
$0.57
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Scenario Analysis
Bear Case
$9.32
1,535.1%
Low target
Base Case
$14.00
+2,356.1%
Avg target
Bull Case
$16.42
+2,780.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.88
-96.2% from high
52-Week Low
$0.31
+83.9% from low
Target vs 52W High
$14.00
-5.9% vs high
Peer Consensus — Pharmaceuticals